MedTrace Logo

Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients

NCT01254955 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2012-01-16

No results posted yet for this study

Summary

Organ transplant patients and staff members at the Transplant Institute have received pandemic H1N1 influenza vaccine (Pandemrix) and specific antibody production was measured by haemagglutination inhibition according to the clinical guidelines and policy, respectively. This study retrospectively assessed the immune response after vaccination.

Conditions

  • Organ Transplantation

Interventions

BIOLOGICAL

H1N1 vaccine Pandemrix

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-01-31
Completion
2011-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01254955 on ClinicalTrials.gov